Allogeneic Mesenchymal Bone Marrow Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic Mesenchymal Bone Marrow Cells, covering 2017-04-27 to 2018-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke [Phase 1, Phase 2]